Connection

Thomas Nathaniel to Thrombolytic Therapy

Back to Details
This is a "connection" page, showing publications Thomas Nathaniel has written about Thrombolytic Therapy.
Thomas Nathaniel
Connection Strength
7.221
Thrombolytic Therapy
  1. Clinical Risk Factors Associated with Ambulatory Outcome in Acute Ischemic Stroke Patient Smokers Treated with Thrombolytic Therapy. Am J Med Sci. 2021 10; 362(4):363-374.
    View in: PubMed
    Score: 0.664
  2. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):104890.
    View in: PubMed
    Score: 0.622
  3. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy? Womens Health (Lond). 2020 Jan-Dec; 16:1745506520922760.
    View in: PubMed
    Score: 0.602
  4. Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity. Neurol Sci. 2019 Sep; 40(9):1829-1839.
    View in: PubMed
    Score: 0.575
  5. Effect of antihypertensive medications on thrombolysis therapy and outcomes in acute ischemic stroke patients. J Clin Hypertens (Greenwich). 2019 02; 21(2):271-279.
    View in: PubMed
    Score: 0.564
  6. Thrombolysis Therapy in Specialized and Non-specialized Stroke Units. Arch Med Res. 2018 11; 49(8):588-597.
    View in: PubMed
    Score: 0.563
  7. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients. BMC Neurol. 2018 Dec 21; 18(1):215.
    View in: PubMed
    Score: 0.560
  8. Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke. Lipids Health Dis. 2018 Sep 27; 17(1):226.
    View in: PubMed
    Score: 0.551
  9. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke. J Stroke Cerebrovasc Dis. 2018 Sep; 27(9):2524-2533.
    View in: PubMed
    Score: 0.539
  10. Pharmacological thrombolysis for acute ischemic stroke treatment: Gender differences in clinical risk factors. Adv Med Sci. 2018 Mar; 63(1):100-106.
    View in: PubMed
    Score: 0.515
  11. Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2569-2574.
    View in: PubMed
    Score: 0.478
  12. Stroke Severity among Men and Women Acute Ischemic Stroke Patients in the Telestroke Network. Cerebrovasc Dis Extra. 2022; 12(2):93-101.
    View in: PubMed
    Score: 0.178
  13. Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy. J Vasc Nurs. 2022 06; 40(2):74-85.
    View in: PubMed
    Score: 0.174
  14. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28:10760296221116347.
    View in: PubMed
    Score: 0.173
  15. Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression. J Vasc Nurs. 2021 Dec; 39(4):91-99.
    View in: PubMed
    Score: 0.168
  16. Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy. BMC Neurol. 2020 May 19; 20(1):197.
    View in: PubMed
    Score: 0.154
  17. Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia. BMC Womens Health. 2019 01 16; 19(1):11.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.